First Time Loading...

Edwards Lifesciences Corp
NYSE:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
NYSE:EW
Watchlist
Price: 85.83 USD 1.33%
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

9.7B
+4%
Assets
Growth Rates:
1 Year
+13%
3 Years
+35%
5 Years
+78%
7 Years
+104%
10 Years
+267%
2.6B
-3%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
+2%
5 Years
+30%
7 Years
+28%
10 Years
+100%
7.1B
+7%
Equity
Growth Rates:
1 Year
+19%
3 Years
+53%
5 Years
+106%
7 Years
+160%
10 Years
+431%

Balance Sheet Decomposition
Edwards Lifesciences Corp

9.7B
Assets
2.6B
Liabilities
9.7B
Assets
2.6B
Liabilities
Current Assets 4.2B
Cash & Short-Term Investments 1.7B
Receivables 876.9m
Other Current Assets 1.6B
Non-Current Assets 5.6B
Long-Term Investments 455.6m
PP&E 1.9B
Intangibles 1.7B
Other Non-Current Assets 1.5B
Current Liabilities 1.1B
Accounts Payable 1.1B
Accrued Liabilities 24.8m
Non-Current Liabilities 1.5B
Long-Term Debt 597.2m
Other Non-Current Liabilities 910.4m

Balance Sheet
Edwards Lifesciences Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
654
718
930
818
714
1 179
1 183
863
769
1 144
Cash Equivalents
654
718
930
818
714
1 179
1 183
863
769
1 144
Short-Term Investments
785
506
341
519
242
338
219
604
446
501
Total Receivables
325
372
415
479
537
599
603
665
699
837
Accounts Receivables
288
315
415
439
457
544
515
582
643
775
Other Receivables
37
56
0
41
80
56
88
83
56
62
Inventory
297
340
397
555
607
641
802
727
876
1 168
Other Current Assets
171
112
158
178
186
227
283
322
306
386
Total Current Assets
2 231
2 048
2 240
2 549
2 287
2 984
3 091
3 181
3 096
4 036
PP&E Net
443
483
580
680
868
1 140
1 489
1 639
1 725
1 843
PP&E Gross
443
483
0
0
868
1 140
1 489
1 639
1 725
1 843
Accumulated Depreciation
365
372
0
0
455
512
599
655
750
857
Intangible Assets
23
205
205
468
343
337
331
324
285
428
Goodwill
376
628
626
1 127
1 112
1 168
1 173
1 168
1 164
1 254
Note Receivable
6
0
0
0
0
0
0
0
0
0
Long-Term Investments
241
380
532
567
506
586
802
1 834
1 239
584
Other Long-Term Assets
203
312
327
276
208
274
351
358
783
1 218
Other Assets
376
628
626
1 127
1 112
1 168
1 173
1 168
1 164
1 254
Total Assets
3 523
N/A
4 056
+15%
4 510
+11%
5 666
+26%
5 324
-6%
6 488
+22%
7 237
+12%
8 503
+17%
8 293
-2%
9 363
+13%
Liabilities
Accounts Payable
56
69
97
117
134
180
197
205
202
1 372
Accrued Liabilities
340
378
418
516
510
643
579
714
668
820
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
598
0
0
0
0
0
0
Other Current Liabilities
31
29
17
189
232
79
119
114
153
174
Total Current Liabilities
426
476
533
1 420
877
902
894
1 032
1 022
1 195
Long-Term Debt
598
597
822
438
594
594
595
596
596
597
Deferred Income Tax
195
195
0
0
125
172
214
0
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
69
Other Liabilities
113
285
536
852
588
671
960
1 039
867
851
Total Liabilities
1 332
N/A
1 553
+17%
1 891
+22%
2 710
+43%
2 183
-19%
2 340
+7%
2 663
+14%
2 667
+0%
2 486
-7%
2 713
+9%
Equity
Common Stock
129
239
243
212
215
218
636
642
646
651
Retained Earnings
2 842
3 337
3 906
1 962
2 695
3 742
4 565
6 068
7 590
8 992
Additional Paid In Capital
878
947
1 168
1 167
1 384
1 623
1 438
1 700
1 969
2 274
Unrealized Security Profit/Loss
0
2
0
5
5
2
9
7
66
25
Treasury Stock
1 557
1 837
2 499
252
1 015
1 279
1 904
2 417
4 144
5 025
Other Equity
101
181
198
128
134
158
170
151
189
218
Total Equity
2 191
N/A
2 503
+14%
2 619
+5%
2 956
+13%
3 140
+6%
4 148
+32%
4 574
+10%
5 836
+28%
5 807
-1%
6 650
+15%
Total Liabilities & Equity
3 523
N/A
4 056
+15%
4 510
+11%
5 666
+26%
5 324
-6%
6 488
+22%
7 237
+12%
8 503
+17%
8 293
-2%
9 363
+13%
Shares Outstanding
Common Shares Outstanding
323
646
635
629
623
627
624
624
608
601

See Also

Summary
EW intrinsic value, competitors valuation, and company profile.
DCF Valuation
EW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EW stock valuation using valuation multiples.
Wall Street Estimates
EW price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.